References
- Petrek H, Yu A-M. MicroRNAs in non-small cell lung cancer: gene regulation, impact on cancer cellular processes, and therapeutic potential. Pharmacol Res Perspect. 2019;7(6):e00528. doi:10.1002/prp2.528
- Parker AL, Bowman E, Zingone A, et al. Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma. Genome Med. 2022;14(1):126. doi:10.1186/s13073-022-01127-6
- Parakh S, Ernst M, Poh AR. Multicellular effects of stat3 in non-small cell lung cancer: mechanistic insights and therapeutic opportunities. Cancers. 2021;13:24. doi:10.3390/cancers13246228
- Zhang Y, Zhang X, Xu Y, et al. Circular RNA and its roles in the occurrence, development, diagnosis of cancer. Front Oncol. 2022;12:845703. doi:10.3389/fonc.2022.845703
- Jia L, Wang Y, Wang C-Y. circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation. Adv Sci. 2021;8(13):2003376. doi:10.1002/advs.202003376
- Peng H, Zhang W, Dong H, et al. CircFAT1 promotes lung adenocarcinoma progression by sequestering miR-7 from repressing IRS2-ERK-mediated CCND1 expression. Int J Biol Sci. 2022;18(10):3944–3960. doi:10.7150/ijbs.70889
- Peña-Romero AC, Orenes-Piñero E. Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers. Cancers. 2022;14:7. doi:10.3390/cancers14071681
- Boieri M, Malishkevich A, Guennoun R, et al. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation. J Exp Med. 2022;219:7. doi:10.1084/jem.20201963
- Ménoret S, Tesson L, Remy S, et al. CD4+ and CD8+ regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model. BMC Biol. 2023;21(1):8. doi:10.1186/s12915-022-01502-0
- Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011;35(2):161–168. doi:10.1016/j.immuni.2011.07.010
- Che L, Yu C, Chen G, et al. The inflammatory response induced by RELMβ Upregulates IL-8 and IL-1β expression in bronchial epithelial cells in COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:2503–2513. doi:10.2147/COPD.S321877
- Yao Y, Li X, Cheng L, Wu X, Wu B. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. Bioengineered. 2021;12(1):4032–4043. doi:10.1080/21655979.2021.1951929
- Pan F, Zhang D, Li N, Liu M. Circular RNA circFAT1(e2) Promotes Colorectal Cancer Tumorigenesis via the miR-30e-5p/ITGA6 Axis. Comput Math Methods Med. 2021;2021:9980459. doi:10.1155/2021/9980459
- Liu G, Huang K, Jie Z, et al. CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells. Mol Cancer. 2018;17(1):170. doi:10.1186/s12943-018-0917-7
- Dong W, Zhang H, Dai Y, et al. circRNA circFAT1(e2) elevates the development of non-small-cell lung cancer by regulating miR-30e-5p and USP22. Biomed Res Int. 2021;2021:6653387. doi:10.1155/2021/6653387
- Wei H, Yan S, Hui Y, et al. CircFAT1 promotes hepatocellular carcinoma progression via miR-30a-5p/REEP3 pathway. J Cell Mol Med. 2020;24(24):14561–14570. doi:10.1111/jcmm.16085
- Marschner N, Zacharias S, Lordick F, et al. Association of disease progression with health-related quality of life among adults with breast, lung, pancreatic, and colorectal cancer. JAMA Netw Open. 2020;3(3):e200643. doi:10.1001/jamanetworkopen.2020.0643
- Verma NK, Wong BHS, Poh ZS, et al. Obstacles for T-lymphocytes in the tumour microenvironment: therapeutic challenges, advances and opportunities beyond immune checkpoint. EBioMedicine. 2022;83:104216. doi:10.1016/j.ebiom.2022.104216
- Schulze AB, Evers G, Görlich D, et al. Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer. J Thorac Dis. 2020;12(5):1824–1842. doi:10.21037/jtd-19-3414a